Synthesis and cytotoxic activity of novel hybrid compounds between 2-alkylbenzofuran and imidazole

Medicinal Chemistry Research

Volumn 23, Issue 3, 2014, Pages 1599-1611

  Wan, Wei Chao ^a   Chen, Wen ^a   Liu, Lan Xiang ^a   Li, Yan ^b   Yang, Li Juan ^c   Deng, Xiao Yan ^a   Zhang, Hong Bin ^a   Yang, Xiao Dong ^a  

^a YUNNAN UNIVERSITY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c YUNNAN MINZU UNIVERSITY   (China)

Author keywords

Benzofuran; Cytotoxic activity; Hybrid compound; Imidazole; Molecular docking; Structure activity relationships

Indexed keywords

EID: 84893728953     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-013-0760-8     Document Type: Article

References (32)

1. Ballistreri FP, Barresi V, Bene-detti P, Caltabiano G, Fortuna CG, Longo ML, Musumarraa G (2004) Design, synthesis and in vitro antitumor activity of new trans 2-[2-(heteroaryl)vinyl]-1,3-dimethylimidazolium iodides. Bioorg Med Chem 12:1689-1695
2. Cao R, Chen QM, Hou X, Chen H, Guan H, Ma Y, Peng W, Xu A (2004) Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives. Bioorg Med Chem 12:4613-4623
3. Cui B, Zheng BL, He K, Zheng QY (2003) Imidazole alkaloids from Lepidium meyenii. J Nat Prod 66:1101-1103
4. Dominianni SJ, Yen TT (1989) Oral hypoglycemic agents: discovery and structure-activity relationships of phenacylimidazolium halides. J Med Chem 32:2301-2306
5. Fortuna CG, Barresi V, Berellini G, Musumarra G (2008) Design and synthesis of trans 2-(furan-2-yl)vinylhetero-aromatic iodides with antitumour activity. Bioorg Med Chem 16:4150-4159
6. Getlik M, Grütter C, Simard JR, Klüter S, Rabiller M, Rode HB, Robubi A, Rauh D (2009) Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc. J Med Chem 52:3915-3926
7. Haque RA, Iqbal MA, Asekunowo P, Majid AMSA, Ahamed MBK, Umar MI, Al-Rawi SS, Al-Suede FSR (2013) Synthesis, structure, anticancer, and antioxidant activity of para-xylyl linked bis-benzimidazolium salts and respective dinuclear Ag(I) N-heterocyclic carbene complexes (Part-II). Med Chem Res. doi: 10.1007/s00044-012-0461-8
8. Haskell CM (2001) Cancer treatment. W.B. Saunders Company, Philadelphia
9. Iqbal MA, Haque RA, Ahamed MBK, Majid AMSA, Al-Rawi SS (2013) Synthesis and anticancer activity of para-xylyl linked bisbenzimidazolium salts and respective Ag(I) N-heterocyclic carbene complexes. Med Chem Res 22:2455-2466
10. Kim D, Ryu DH, Lee JY, Lee N, Kim Y, Kim J, Chang K, Im G, Kim T, Choi W (2001) Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues. J Med Chem 44:1594-1602
11. Kim S, Park I, Song K (2002) Kynapcin-13 and -28, new benzofuran prolyl endopeptidase inhibitors from Polyozellus multiplex. J Antibiot 55:623-628
12. Miert SV, Dyck SV, Schmidt TJ, Brun R, Vlietinck A, Lemiere G, Pieters L (2005) Antileishmanial activity, cytotoxicity and QSAR analysis of synthetic dihydrobenzofuran lignans and related benzofurans. Bioorg Med Chem 13:661-669
13. Mohamed M, Manly SP, Lupien S, Dugan FM, Hill RA, Cutler HG (2011) Benzyl derivatives with in vitro binding affinity for human opioid and cannabinoid receptors from the fungus Eurotium repens. J Nat Prod 74:1636-1639
14. Newman DJ (2008) Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem 51:2589-2599
15. Ng TB, Liu F, Wang ZT (2000) Antioxidative activity of natural products from plants. Life Sci 66:709-723
16. Ojima I (2008) Modern natural products chemistry and drug discovery. J Med Chem 51:2587-2588
17. Ortial S, Denoyelle S, Wein S, Berger O, Durand T, Escale R, Pellet A, Vial H, Vo-Hoang Y (2010) Synthesis and evaluation of hybrid bis-cationic salts as antimalarial drugs. ChemMedChem 5:52-55
18. Pautus S, Yee SW, Jayne M, Coogan MP, Simons C (2006) Synthesis and CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]- 1H-triazoles. Bioorg Med Chem 14:3643-3653
19. Podea PV, Toşa MI, Paizs C, Irimie FD (2008) Chemoenzymatic preparation of enantiopure l-benzofuranyl- and l-benzo[b]thiophenyl alanines. Tetrahedron Asymmetry 19:500-511
20. Ranke J, Stolte S, Störmann R, Arning J, Jastorff B (2007) Design of sustainable chemical products - the example of ionic liquids. Chem Rev 107:2183-2206
21. Ruchelman AL, Muller GW, Man HW (2008) 4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same. WO2008/115516 A2
22. Song HS, Raskin I (2002) A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex. J Nat Prod 65:76-78
23. Song WJ, Yang XD, Zeng XH, Xu XL, Zhang GL, Zhang HB (2012) Synthesis and cytotoxic activities of novel hybrid compounds of imidazole scaffold-based 2-substituted benzofurans. RSC Adv 2:4612-4615
24. Tseng C, Li C, Chiu C, Hu H, Han C, Chen Y, Tzeng C (2012a) Combretastatin A-4 derivatives: synthesis and evaluation of 2,4,5-triaryl-1H- imidazoles as potential agents against H1299 (non-small cell lung cancer cell). Mol Divers 16:697-709
25. Tseng C, Tzeng C, Shih P, Yang C, Chuang Y, Peng S, Lin C, Wang J, Cheng C, Chen Y (2012b) Identification of furo[3′,2′:3,4]naphtho[1,2-d] imidazole derivatives as orally active and selective inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1). Mol Divers 16:215-229
26. Varmus H (2006) The new era in cancer research. Science 312:1162-1165
27. Viegas JC, Danuello A, Bolzani VS, Barreiro EJ, Fraga CAM (2007) Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem 14:1829-1852
28. Vik A, Hedner E, Charnock C, Tangen LW, Samuelsen Ø, Larsson R, Bohlinb L, Gundersen LL (2007) Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs. Bioorg Med Chem 15:4016-4037
29. Wang XQ, Liu LX, Li Y, Sun CJ, Chen W, Li L, Zhang HB, Yang XD (2013) Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents. Eur J Med Chem 62:111-121
30. Yang XD, Zeng XH, Zhang YL, Qing C, Song WJ, Li L, Zhang HB (2009) Synthesis and cytotoxic activities of novel phenacylimidazolium bromides. Bioorg Med Chem Lett 19:1892-1895
31. Zeng XH, Yang XD, Zhang YL, Qing C, Zhang HB (2010) Synthesis and antitumor activity of 1-mesityl-3-(2-naphthoylmethano)-1H-imidazolium bromide. Bioorg Med Chem Lett 20:1844-1847
32. Zhang GN, Zhong LY, Bligh SWA, Guo YL, Zhang CF, Zhang M, Wang ZT, Xu LS (2005) Bi-bicyclic and bi-tricyclic compounds from Dendrobium thyrsiflorum. Phytochemistry 66:1113-1120